新冠病毒变异株（VOCs）不断涌现，导致新冠疫情反复，现有疗法效果受限。研究人员开展 “植物源 ACE2-Fc 诱饵蛋白对 SARS-CoV-2 变异株的中和作用及治疗效果研究”，发现该蛋白能有效中和多种变异株，在仓鼠模型中可减轻体重下降和肺部病毒复制，为抗病毒 ...

The spike protein of the coronavirus, or SARS-CoV-2, binds to ACE2, a receptor on the host cells, which allows the virus to enter the cells and infect it. Binding is the first step for infection, and ...

Cardiovascular diseases are the world's leading cause of death, and high blood pressure, or hypertension, affects more than 1 ...

As compared to controls, elevated nasal levels of ACE2 and TMPRSS2 were associated with a 3.6-fold increased risk of SARS-CoV ...

When the SARS-CoV-2 virus enters the human body, it breaks into cells with the help of two proteins that it finds there, ACE2 and TMPRSS2. While there has been much discussion of viral infection in ...

Historically, these viruses primarily use the DPP4 receptor for cell entry. Analysis revealed HKU5-CoV-2's utilization of ...

SARS-CoV-2, the virus responsible for COVID-19, infects cells by binding its spike protein to angiotensin-converting enzyme 2 (ACE2) receptors. Blocking this interaction with inhibitors could prevent ...